Cell Therapeutics secures reimbursement for Pixuvri in Germany
This article was originally published in Scrip
Executive Summary
Cell Therapeutics (CTI) has reached an agreement with the German National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) for reimbursement of its non-Hodgkin’s lymphoma drug Pixuvri (pixatrone).